Inflammatory Bowel Disease and Atherosclerosis Development

Active, not recruiting

• Conditions: Inflammatory Bowel Diseases; Cardiovascular Diseases; Inflammation; Arterial Stiffness

• Registration Number: NCT05781737
• Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Brief Summary

The study will show the influence of inflammatory bowel disease on the risk of development of atherosclerosis

Detailed Description

Not available

Study Timeline

• Study Start: 2022-11-01
• Study First Submitted: 2023-01-16
• Study First Submitted QC: 2023-03-12
• Study First Posted: 2023-03-23
• Primary Completion: 2024-01-30
• Status Verified: 2024-10
• Last Update Submitted: 2024-10-03
• Last Update Posted: 2024-10-04
• Study Completion: 2025-01-30

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 115

Inclusion Criteria

• Inflammatory bowel disease
• Signed informed consent

Exclusion Criteria

• Pregnancy
• Other conditions affecting the prognosis
• Psychiatric disorders affecting the participation in the study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intima-media thickness	1 year	Intima-media thickness
Pulse wave velocity	1 year	Pulse wave velocity

Secondary Outcome Measures

Name	Time	Method
Hospitalisation due to cardiovascular disease	1 year
All cause mortality	1 year
Cardiovascular mortality	1 year

Trial Locations

Locations (1)

University Hospital #1; 🇷🇺 Moscow, Russian Federation